乐天堂fun88

  • 64549fb9ded7a
    Cancel
    Date：2023-04
    /index.php?a=shows&catid=34&id=711

    Shanghai Winning Health Software Technology Co., Ltd. ("Winning Health") recently raised RMB 300 million in its Series C financing round. The investment was led exclusively by Taiping Medical and Health Industry Fund, a subsidiary of China Taiping Insuran

  • 644a28df34484
    Cancel
    Date：2023-04
    /index.php?a=shows&catid=34&id=712

    Hangzhou Wanxiang Cultural Technology Co., Ltd. (" WanXiang Tech " or “Company”), a frontrunner in China's virtual content domain, successfully closed an A2 financing round worth tens of millions of RMB. In this funding round, existing shareholder Porsche Ventures increased its investment, and several strategic investment institutions also participated. CEC Capital acted as the exclusive financial advisor for Wanxiang Tech in this transaction.

  • 6437694b21ddf
    Cancel
    Date：2023-04
    /index.php?a=shows&catid=34&id=707

    Hangzhou Diagens Biotechnology Co., Ltd. ("Diagens Biotechnology" or "the Company"), a leading reproductive health company in China, recently closed a financing round of RMB 100+ million. This round was led by Grand Flight Investment, with participation f

  • 671f1e5be661c
    Cancel
    Date：2023-03
    /index.php?a=shows&catid=34&id=710

    Qingdao PHAGEPHARM Biotechnology Co., Ltd. ("PHAGEPHARM" or “Company”), a leading domestic provider of phage-resistant comprehensive solutions, completed a Series B financing round of nearly RMB 100 million. This financing was led by Cenova Capital, with participation from Morningside Ventures and two existing shareholders. CEC Capital served as exclusive financial advisor for this transaction.

  • 63e06b87adaab
    Cancel
    Date：2023-02
    /index.php?a=shows&catid=34&id=713

    NEXIC Technology, a company specializing in silicon carbide (SiC) power semiconductors, recently secured several hundred million yuan through its Series B and B+ financing rounds. The round was led by Xinchao Innovation Investment Group and JP Xinchao Cap

  • 6655513c6bc82
    Cancel
    Date：2023-02

    Exclusive Financial Advisor to Concare

  • 63bfded8c5d27
    Cancel
    Date：2022-12
    /index.php?a=shows&catid=34&id=718

    OYMotion Technologies secured nearly RMB 100 million in its Series C funding round. The funding round was led by Intelligent Interconnection Industry Fund, a subsidiary of Qianhai Ark Industrial Fund, and Zhongyuan Qianhai Fund. XingTuo Capital, Zhang Y

  • 63c77dfe7e10a
    Cancel
    Date：2022-12
    /index.php?a=shows&catid=34&id=719

    Sinovation (Beijing) Medical Technology Co., Ltd. (referred to as Sinovation), a leading Chinese intelligent platform for minimally invasive neurosurgery, recently announced the closing of nearly RMB 300 million in Series D financing. The round was led by

  • 63c515f178435
    Cancel
    Date：2022-12
    /index.php?a=shows&catid=34&id=721

    BioMérieux recently entered a strategic investment partnership with Accunome Biotechnology Co., Limited ("Accunome"), which includes an equity investment and an exclusive distribution agreement. This partnership signifies a deep collaboration between BioM


【网站地图】